borderline tumor

borderline tumor

Surgical pathology A term used for neoplasms with many histologic criteria of malignancy, for which the future behavior is uncertain. See Stump.
References in periodicals archive ?
Coexistence of three benign and a borderline tumor in the ovaries of 52-year-old women.
The final histologic examination objectified intracystic intestinal type ovarian mucinous borderline tumor which corresponded to a Demons' pseudosyndrome.
Fortunately, my pathology came back better than expected and I was diagnosed with a borderline tumor, which is a low-malignant form of the disease.
In addition to serous borderline tumors, one mucinous borderline tumor and two mucinous ovarian carcinomas exhibited the same mutation at codon 12 (Gly to Asp).
24) Moh et al (23) examined SATB2 expression in 111 primary ovarian tumors and 46 colorectal/appendiceal ovarian metastases, and found SATB2 expression in 1 borderline tumor and no adenocarcinomas versus 78% of the metastases.
However, for patients who have had fertility-sparing surgery, imaging with pelvic ultrasound is recommended, particularly for women with a history of cystectomy or serous borderline tumor.
7) HL can also mimic ovarian malignancies like mucinous borderline tumor of intestinal type; however, they are differentiated by the fact that they have smaller thin-walled cysts and not as much solid component as seen in HL.
Prognostic significance for histologic grading as well as lymphovascular invasion (LVI) is limited to node-negative breast cancers, with borderline tumor sizes.
For the purpose of this study, proliferating trichilemmal tumor is considered in malignant category as described in WHO manual although the International classification of diseases for oncology (ICD-O) considers it to be a borderline tumor.
Long-term outcomes following conservative surgery for borderline tumor of the ovary: a large population based study.
9) This entity parallels the more commonly encountered and familiar intraductal papillary mucinous neoplasm (IPMN) of the pancreas, in that the tumors range from benign to malignant, and are classified as adenoma, borderline tumor, carcinoma in situ, or carcinoma, though most cases are reportedly at least carcinoma in situ, a distinction from IPMN of the pancreas.
The World Health Organization classification divides IPMT intraductal epithelial dysplasia into adenoma, borderline tumor, and carcinoma.